Omeprazolo Sun (Omeprazole)

Omeprazole, the active ingredient in Omeprazolo Sun, is a proton pump inhibitor presented as a oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as GERD, peptic ulcer disease and other acid‑related disorders in adults. GNH USA supplies Omeprazolo Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazolo Sun is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑esophageal reflux disease (GERD): Improves symptom control and promotes healing of esophageal irritation. - Peptic ulcer disease: Facilitates ulcer healing by maintaining a less acidic gastric environment. - NSAID‑induced gastric ulcer: Reduces risk of ulcer formation and supports mucosal protection. - Zollinger‑Ellison syndrome: Controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication (as part of combination therapy): Enhances the effectiveness of antibiotic regimens by suppressing acid production.

Adverse reactions to omeprazole may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: typically self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatic stress. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When using Omeprazolo Sun, consider the following safety measures: - Assess renal function: adjust use in patients with severe renal impairment. - Evaluate hepatic function: use cautiously in moderate to severe liver disease. - Monitor long‑term therapy: periodic assessment for bone health and magnesium levels. - Review concomitant medications: assess for potential drug‑interaction risks. - Pregnancy and lactation: weigh benefits against potential risks; consult a prescriber. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazolo Sun can affect the absorption and metabolism of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: markedly decreased antiviral exposure. - Dasatinib: lowered plasma concentrations, reducing efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring more frequent monitoring. - Phenytoin: possible reduction in seizure‑control levels. - Methotrexate: elevated serum concentrations, especially at high doses.